2026 ECNP Congress

PS03-3237

When diagnostic stability misleads: emerging cognitive decline after late-onset psychosis

Ana Luís Falcão — A.R. Henriques, I. Vidó, J. Reis · Hospital Júlio de Matos- ULS S. José, Clínica 2, Lisboa, Portugal

Background

Late-onset psychosis is increasingly recognised as a potential clinical marker of underlying neurodegenerative disease, particularly in older adults without prior psychiatric history. However, initial presentations may closely resemble primary psychotic disorders, such as delusional disorder, with typical phenomenology and good response to antipsychotic treatment. This may confer a misleading sense of diagnostic stability, potentially delaying recognition of an evolving neurocognitive disorder. Furthermore, the absence of overt neurological signs or early cognitive impairment at presentation may reinforce a primary psychiatric formulation, despite the known association between late-life psychosis and subsequent cognitive decline.

Objectives

To illustrate the diagnostic significance of emerging cognitive decline following an initially stable presentation of late-onset psychosis, and to explore the challenges of differentiating primary psychotic disorders from early neurodegenerative processes.

Methods

We report the case of a 72-year-old man with no prior psychiatric history, admitted for a first episode of psychosis characterised by well-systematised persecutory delusions, without hallucinations or formal thought disorder. There was no evidence of delirium, substance use, or acute medical illness at presentation. The patient showed good clinical response to risperidone, with resolution of psychotic symptoms and restoration of baseline functioning. A diagnosis of delusional disorder was established and maintained over six months of outpatient follow-up. Subsequently, subtle cognitive concerns were raised by a family member, prompting further evaluation.

Results

Initial clinical assessment did not reveal clear or consistent cognitive deficits, and the patient did not endorse significant impairment or functional decline. However, given the late onset of psychosis and emerging concerns, structured neuropsychological assessment was undertaken. This revealed early deficits in executive function and episodic memory, with relative preservation of other cognitive domains. Repeat assessment over the following months demonstrated significant progression, with increasing impairment and emerging functional impact. The rapid cognitive deterioration, in conjunction with the prior psychiatric presentation, supported the diagnosis of an evolving neurocognitive disorder. The initial psychotic episode was retrospectively reinterpreted as a possible early manifestation of an underlying neurodegenerative process.

Discussion

This case highlights a critical diagnostic challenge in late-life psychiatry: distinguishing primary psychotic disorders from psychosis secondary to neurodegeneration. Late-onset delusional presentations may represent prodromal or early-stage manifestations of neurocognitive disorders, including Alzheimer’s disease and related dementias. A favourable response to antipsychotic treatment and an initially coherent clinical picture may reinforce diagnostic certainty and contribute to diagnostic inertia. However, the later emergence of cognitive deficits—particularly when progressive and supported by neuropsychological findings—constitutes a key diagnostic turning point. The temporal dissociation between psychiatric and cognitive symptoms may obscure their underlying unity, especially when early cognitive changes are subtle or inconsistently expressed. This underscores the importance of maintaining a high index of suspicion and integrating longitudinal cognitive assessment into the follow-up of late-onset psychosis.

Conclusions

Late-onset psychosis should be approached as a potentially evolving neuropsychiatric condition rather than a fixed diagnostic entity. The emergence of progressive cognitive deficits after an initially stable course represents a critical signal for underlying neurodegeneration. Early recognition of this trajectory has important implications for diagnosis, prognosis, and clinical management.

References

No references